诺诚健华:港股公告:根据二零一八年首次公开发售前激励计划授予受限制股份单位2023-04-01
InnoCare Pharma Limited
9969)
17.06A
8 1,110,000
0.06%
(i) 610,000
(ii) 500,000
0.178 1.40
(i) 8.37
(ii) 11.84 13.53
1
(i)
(ii)
17.03D 1% (iii)
12 0.1%
2
51,366,607
3
9969
688428
17.03A
1,110,000
1,110,000
17.03A
4
17.03A
0.00002
%
5